You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Rapid Diagnostic Testing of Urinary Tract Infections

    SBC: BIOSENSE TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Abstract The continued development of a rapid diagnostic method for testing the antibiotic susceptibility of urinary tract infections in near real-time is proposed. Currently, all methods for determining antibiotic susceptibility rely exclusively on detecting changes in the bacterial population caused by cell division after exposure to an antim ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  2. A Bioactive Prosthetic Vascular Graft

    SBC: BIOSURFACES INC            Topic: N/A

    DESCRIPTION (provided by applicant): Over 60,000 prosthetic grafts, which are comprised of either polyethylene terephthalate (polyester) or expanded polytetrafluoroethylene (ePTFE), are implanted in the United States each year. Medium (6-8mm) and small (l t5mm) internal diameter (I.D.) prosthetic arterial grafts continue to have unacceptably high failure rates when used in the clinical setting. T ...

    STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  3. An Endothelial Progenitor Cell-Specific Nanofibrous Vascular Graft

    SBC: BIOSURFACES INC            Topic: N/A

    DESCRIPTION (provided by applicant): Over 60,000 prosthetic grafts, which are comprised of either polyethylene terephthalate (polyester) or expanded polytetrafluoroethylene (ePTFE), are implanted in the United States each year. Medium (6-8mm) internal dia meter (I.D.) prosthetic arterial grafts continue to have unacceptably high failure rates when used in the clinical setting. Currently, there is ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  4. DNA PROBES FOR ANTIBIOTIC RESISTANCE IN PERIODONTITIS

    SBC: Biotechnica Diagnostics Inc            Topic: N/A

    THE USE OF ANTIBIOTIC THERAPY FOR INFECTION MANAGEMENT HAS INCREASED DRAMATICALLY IN THE AREA OF PERIODONTAL DISEASE AS AN ADJUNCT TO SCALING AND SURGERY TREATMENT. WITH THE EMERGENCE OF ANTIBIOTIC USE IN PERIODONTAL DISEASE CARE, ALMOST NO WORK HAS BEEN DONE IN ASSESSING THE DEVELOPMENT OF ANTIBIOTIC RESISTANCE IN DENTAL PLAQUE FLORA. BY DEVELOPING A DNA PROBE-BASED ASSAY FOR THE DETECTION OF ANT ...

    SBIR Phase I 1988 Department of Health and Human Services
  5. DNA PROBES FOR THE DETECTION OF PERIODONTAL PATHOGENS

    SBC: Biotechnica Diagnostics Inc            Topic: N/A

    THE ROLE OF EIKENELLA CORRODENS, FUSOBACTERIUM NUCLEATUM, AND WOLINELLA RECTA AS PATHOGENS ASSOCIATED IN DESTRUCTIVE PERIODONTAL DISEASE HAS BEEN DESCRIBED IN A NUMBER OF STUDIES USING CULTURE BASED ASSAY SYSTEMS. THE STANDARD CULTURE METHODS ARE INADEQUATE FOR THE ROUTINE DIAGNOSIS OF THESE PATHOGENS. BY DEVELOPING DNA PROBE-BASED ASSAYS FOR THE DETECTION OF THESE PATHOGENS, IT WOULD BE PRACTICAL ...

    SBIR Phase I 1988 Department of Health and Human Services
  6. DEVELOPMENT OF TRANSDERMAL ANTIHISTAMINE DELIVERY SYSTEM

    SBC: BIOTEK, INC.            Topic: N/A

    THE OVERALL OBJECTIVE OF THE PROJECT IS TO DEVELOP A TRANSDERMAL DOSAGE FORM OF THE H(1)-BLOCKER CARBINOXAMINE FOR 24-HOUR CONTROL OF ALLERGIC RHINITIS. IN PHASE I THE FEASIBILITY OF SUCH DOSAGE WILL BE TESTED. IN VITRO TRANSDERMAL PENETRATION EXPERIMENTS WITH NUDE MOUSE SKINS, AS WELL AS IN VIVO TESTS ON SHAVED RABBIT SKINS WILL BE USEDTO DETERMINE PERCUTANEOUS FLUX VALUES. FORMULATIONS OPTIMIZED ...

    SBIR Phase I 1988 Department of Health and Human Services
  7. ONE WEEK SUSTAINED RELEASE METHADONE MICROCAPSULES

    SBC: BIOTEK, INC.            Topic: N/A

    N/A

    SBIR Phase I 1988 Department of Health and Human Services
  8. New deubiquitinating enzymes, poly-ubiquitin substrates and assays.

    SBC: BOSTON BIOCHEM, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Deubiquitinating enzymes play critical regulatory roles in the ubiquitin-proteasome pathway (UPP). Despite their relevance to human disease and interest by pharma as targets for therapeutic development, this diverse cla ss of enzymes is understudied and detailed biochemical data is lacking. Highly purified DUB enzymes and appropriate substrates for sensitive an ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  9. Cancer targeted therapy through bacterial RNAi

    SBC: BOSTON BIOMEDICAL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The recent discovery of RNAi has created the opportunity to develop an entirely new class of drugs against a variety of human diseases that work by silencing disease causing genes. The development of RNAi-based drugs, h owever, has been hampered by difficulties in delivery and manufacturing, as well as the activation of host interferon-like responses. Of these, ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  10. ASBESTOS TOXICITY AND CARCINOGENICITY

    SBC: BOSTON BIOTECHNOLOGY CORPORATION            Topic: N/A

    THE LONG RANGE OBJECTIVE OF THIS RESEARCH IS TO REDUCE THE TOXICITY AND CARCINOGENICITY OF ASBESTOS BY DESFERROXAMINE TREATMENT, WHICH NEUTRALIZES THE CATALYTIC ACTIVITY OF THE ASBESTOS-CONTAINED IRON. IN PHASE I OF THIS PROJECT THE POSSIBILITY THAT DESFERROXAMINE TREATMENT CAN REDUCE ASBESTOS-CAUSED SQUAMOUS METAPLASIA IN TRACHEAL ORGAN CULTURES WILL BE STUDIED. SQUAMOUS METAPLASIA IS THOUGHT TOP ...

    SBIR Phase I 1988 Department of Health and Human Services
US Flag An Official Website of the United States Government